Stockscreener 앱 받기
6.36
4.26%
0.26
전일 마감가:
$6.10
열려 있는:
$6.06
하루 거래량:
19,155
Relative Volume:
0.10
시가총액:
$70.64M
수익:
$2.09M
순이익/손실:
$-5.28M
주가수익비율:
-9.4925
EPS:
-0.67
순현금흐름:
$-3.64M
1주 성능:
-8.49%
1개월 성능:
-10.67%
6개월 성능:
+45.54%
1년 성능:
+170.64%
1일 변동 폭
$6.05
$6.49
1주일 범위
$6.00
$7.05
52주 변동 폭
$2.22
$11.78
Nutriband Inc Stock (NTRB) Company Profile
명칭
Nutriband Inc
전화
407 377-6695
주소
121 S. ORANGE AVE., ORLANDO
NTRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
6.36 | 70.64M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.42 | 127.22B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
689.50 | 75.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.45 | 35.94B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.43 | 31.38B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.84 | 26.84B | 3.32B | -860.46M | -1.04B | -8.32 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-22 | 개시 | Noble Capital Markets | Outperform |
Nutriband Inc 주식(NTRB)의 최신 뉴스
Breakeven On The Horizon For Nutriband Inc. (NASDAQ:NTRB) - Simply Wall St
When the Price of (NTRB) Talks, People Listen - Stock Traders Daily
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch - ACCESS Newswire
Nutriband Inc, Orlando - Florida Trend
Nutriband Inc. to Present at the Emerging Growth Conference on May 25 - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May - ACCESS Newswire
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4 - ACCESS Newswire
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology - ACCESS Newswire
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M - ACCESS Newswire
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company - ACCESS Newswire
(NTRB) Long Term Investment Analysis - Stock Traders Daily
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary - ACCESS Newswire
Nutriband Receives Certificate of Registration for - GlobeNewswire
Nutriband secures trademark for drug abuse deterrent tech By Investing.com - Investing.com Nigeria
Nutriband secures trademark for drug abuse deterrent tech - Investing.com
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - The Manila Times
Can This New Trademark Help Nutriband Capture a $200M Drug Delivery Market? - StockTitan
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 - ACCESS Newswire
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
This Surging Pharma Company Could Hit Profitability by 2027 - Elblog.pl
When Will Nutriband Inc. (NASDAQ:NTRB) Breakeven? - Yahoo Canada Finance
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023 - ACCESS Newswire
Nutriband partners with Kindeva for opioid patch development - MSN
Nutriband partners with Kindeva for opioid patch development By Investing.com - Investing.com Nigeria
Short Interest in Nutriband Inc. (NASDAQ:NTRB) Rises By 377.4% - MarketBeat
Nutriband Expands Partnership with Kindeva for Aversa™ - TipRanks
Where are the Opportunities in (NTRB) - Stock Traders Daily
Nutriband Formalizes Development Partnership for Abuse Deterrent Fentanyl Patch With Kindeva - Marketscreener.com
Nutriband and Kindeva Drug Delivery Formalize Exclusive - GlobeNewswire
Nutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent Patch - Contract Pharma
Nutriband And Kindeva Drug Delivery Formalize Exclusive Development Partnership For Aversa Fentanyl Abuse Deterrent Fentanyl Patch - Marketscreener.com
Nutriband, Kindeva Drug Delivery formalize exclusive development partnership - TipRanks
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa - The Bakersfield Californian
Revolutionary Abuse-Deterrent Fentanyl Patch Development: $200M Market Potential - StockTitan
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape - ACCESS Newswire
NutriBand secures patent for abuse deterrent technology By Investing.com - Investing.com Nigeria
NutriBand secures patent for abuse deterrent technology - MSN
Nutriband Secures USPTO Notice for Aversa™ Technology - TipRanks
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board - GlobeNewswire
Noble Capital Markets analysts initates an Outperform rating for Nutriband Inc (NTRB) - Knox Daily
Nutriband Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Upward Trajectory: Nutriband Inc (NTRB) Posts a Gaine, Closing at 7.81 - The Dwinnex
Nutriband secures US patent for abuse deterrent patch - MSN
Nutriband receives notice of allowance for new U.S. Patent for its transdermal abuse deterrent technology; shares rise - MSN
Nutriband Inc trading halted, volatility trading pause - MSN
Nutriband Receives Notice Of Allowance For New U.S. Patent - GlobeNewswire
Game-Changing Patent Win: Nutriband's Abuse-Proof Fentanyl Patch Could Hit $200M in Sales - StockTitan
Nutriband Inc (NTRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.70%
자본화:
|
볼륨(24시간):